Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LPO | P22079 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4057810 | 0.84 | KDM4E (0.50) | KDM4ECYP2D6L3MBTL1SMN1; SMN2LPO | |
| SCHEMBL4065140 | 0.78 | KDM4E (0.52) | KDM4ECYP2D6L3MBTL1SMN1; SMN2LPO | |
| SCHEMBL2474436 | 0.77 | KDM4E (0.43) | KDM4ECYP2D6L3MBTL1SMN1; SMN2LPO | |
| SCHEMBL4060494 | 0.77 | KDM4E (0.44) | KDM4ECYP2D6L3MBTL1SMN1; SMN2LPO | |
| SCHEMBL4065142 | 0.76 | KDM4E (0.50) | KDM4ECYP2D6L3MBTL1SMN1; SMN2LPO | |
| SCHEMBL48851 | 0.76 | — | — | |
| SCHEMBL14148932 | 0.76 | L3MBTL1 (0.46) | KDM4ECYP2D6L3MBTL1SMN1; SMN2LPO | |
| SCHEMBL1503496 | 0.75 | KDM4E (0.63) | KDM4ECYP2D6L3MBTL1MAPTTSHR | |
| SCHEMBL1697176 | 0.74 | — | — | |
| SCHEMBL19143605 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7553988-B2 | Method for producing coupling compound | SUMITOMO CHEMICAL COMPANY, LIMTED (JP) | 2009-06-30 | — | — | US | claimed |
| US-7553988-B2 | Method for producing coupling compound | SUMITOMO CHEMICAL COMPANY, LIMTED (JP) | 2009-06-30 | — | — | US | disclosed |
| EP-1439157-B1 | Method for producing Suzuki coupling compound catalysed by a nickel compound | SUMITOMO CHEMICAL CO (JP) | 2007-07-11 | — | — | EP | disclosed |
| US-7217677-B2 | Method for producing coupling compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-05-15 | — | — | US | disclosed |
| US-20060281925-A1 | METHOD FOR PRODUCING COUPLING COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-12-14 | — | — | US | disclosed |
| US-20040161404-A1 | Method for producing coupling compound | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-08-19 | — | — | US | disclosed |
| EP-1439157-A2 | Method for producing Suzuki coupling compound catalysed by a nickel compound | Sumitomo Chemical Co.,Ltd. (JP) | 2004-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060281925-A1 | METHOD FOR PRODUCING COUPLING COMPOUND | RPL22, CYP4A22, PYM1 | KDM4E 4615/4885CYP2D6 1373/4885L3MBTL1 4107/4885 |
| US-20040161404-A1 | Method for producing coupling compound | PYM1, MALT1, BET1 | KDM4E 4304/4885CYP2D6 2500/4885L3MBTL1 2180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.